AIM ImmunoTech Inc.

AIM · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3,284-$2,794-$3,705-$5,967
Dep. & Amort.$54$55$58$64
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$60$196
Change in WC-$2,326$783$790$1,415
Other Non-Cash$477$425$436$337
Operating Cash Flow-$5,079-$1,531-$2,361-$3,955
Investing Activities
PP&E Inv.$0-$227-$56-$119
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$91-$203
Inv. Sales/Matur.$296$981$1,045$4,026
Other Inv. Act.$0$0$0$0
Investing Cash Flow$296$754$898$3,704
Financing Activities
Debt Repay.$7,052$250$0-$2,298
Stock Issued-$398$105$660$32
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$3,303
Financing Cash Flow$6,654$355$660$1,037
Forex Effect$0$0$0$0
Net Chg. in Cash$1,871-$422-$803$786
Supplemental Information
Beg. Cash$476$898$1,701$915
End Cash$2,347$476$898$1,701
Free Cash Flow-$5,079-$1,758-$2,417-$4,074